Glycogen synthase kinase 3β (GSK3β) modulates antiviral activity of zinc-finger antiviral protein (ZAP)

Journal of Biological Chemistry

Volumn 287, Issue 27, 2012, Pages 22882-22888

  Sun, Lin ^a   Lv, Fengxiang ^a   Guo, Xuemin ^a   Gao, Guangxia ^a  

^a INSTITUTE OF BIOPHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRAL ACTIVITIES; ANTIVIRAL PROTEIN; CELLULAR MRNAS; DOWN-REGULATION; EBOLA VIRUS; GLYCOGEN SYNTHASE KINASE-3;

DEGRADATION; DISEASES; MACHINERY; PHOSPHORYLATION; RNA; ZINC;

VIRUSES;

2 (2,4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL)MALEIMIDE; GLYCOGEN SYNTHASE KINASE 3BETA; HOST FACTOR; MESSENGER RNA; SERINE; SERINE 257; SERINE 262; SERINE 266; SERINE 270; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA; ZINC FINGER PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; DOWN REGULATION; EBOLA VIRUS; ENZYME INHIBITION; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SINDBIS VIRUS;

ANIMALS; CARRIER PROTEINS; GENE LIBRARY; GLYCOGEN SYNTHASE KINASE 3; HEK293 CELLS; HUMANS; INDOLES; LENTIVIRUS; LENTIVIRUS INFECTIONS; MALEIMIDES; PHOSPHORYLATION; RATS; RNA, SMALL INTERFERING; RNA, VIRAL; SERINE; THREONINE;

EBOLA VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RATTUS; SINDBIS VIRUS;

EID: 84863318601     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.306373     Document Type: Article

References (34)

1. Gao, G., Guo, X., and Goff, S. P. (2002) Inhibition of retroviral RNA production by ZAP, a CCCH-type zinc-finger protein. Science 297, 1703-1706 (Pubitemid 35000785)
2. Zhu, Y., Chen, G., Lv, F., Wang, X., Ji, X., Xu, Y., Sun, J., Wu, L., Zheng, Y. T., and Gao, G. (2011) Zinc-finger antiviral protein inhibits HIV-1 infection by selectively targeting multiply spliced viral mRNAs for degradation. Proc. Natl. Acad. Sci. U.S.A. 108, 15834-15839
3. Müller, S., Möller, P., Bick, M. J., Wurr, S., Becker, S., Günther, S., and Kümmerer, B. M. (2007) Inhibition of filovirus replication by the zincfinger antiviral protein. J. Virol. 81, 2391-2400
4. Zhang, Y., Burke, C. W., Ryman, K. D., and Klimstra, W. B. (2007) Identification and characterization of interferon-induced proteins that inhibit alphavirus replication. J. Virol. 81, 11246-11255 (Pubitemid 47536097)
5. Bick, M. J., Carroll, J. W., Gao, G., Goff, S. P., Rice, C. M., and MacDonald, M. R. (2003) Expression of the zinc-finger antiviral protein inhibits alphavirus replication. J. Virol. 77, 11555-11562 (Pubitemid 37271654)
6. Wang, N., Dong, Q., Li, J., Jangra, R. K., Fan, M., Brasier, A. R., Lemon, S. M., Pfeffer, L. M., and Li, K. (2010) Viral induction of the zinc-finger antiviral protein is IRF3-dependent but NF-κB-independent. J. Biol. Chem. 285, 6080-6090
7. MacDonald, M. R., Machlin, E. S., Albin, O. R., and Levy, D. E. (2007) The zinc-finger antiviral protein acts synergistically with an interferon-induced factor for maximal activity against alphaviruses. J. Virol. 81, 13509-13518 (Pubitemid 350247845)
8. Chen, G., Guo, X., Lv, F., Xu, Y., and Gao, G. (2008) p72 DEAD box RNA helicase is required for optimal function of the zinc-finger antiviral protein. Proc. Natl. Acad. Sci. U.S.A. 105, 4352-4357 (Pubitemid 351754384)
9. Embi, N., Rylatt, D. B., and Cohen, P. (1980) Glycogen synthase kinase 3 from rabbit skeletal muscle. Separation from cyclic AMP-dependent protein kinase and phosphorylase kinase. Eur. J. Biochem. 107, 519-527
10. Woodgett, J. R. (1990) Molecular cloning and expression of glycogen synthase kinase 3/factor A. EMBO J. 9, 2431-2438
11. Fiol, C. J., Mahrenholz, A. M., Wang, Y., Roeske, R. W., and Roach, P. J. (1987) Formation of protein kinase recognition sites by covalent modification of the substrate. Molecular mechanism for the synergistic action of casein kinase II and glycogen synthase kinase 3. J. Biol. Chem. 262, 14042-14048
12. Frame, S., Cohen, P., and Biondi, R. M. (2001) A common phosphate-binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. Mol. Cell 7, 1321-1327 (Pubitemid 32607364)
13. Guo, X., Ma, J., Sun, J., and Gao, G. (2007) The zinc-finger antiviral protein recruits the RNA-processing exosome to degrade the target mRNA. Proc. Natl. Acad. Sci. U.S.A. 104, 151-156 (Pubitemid 46068000)
14. Wang, X., Lv, F., and Gao, G. (2010) Mutagenesis analysis of the zinc-finger antiviral protein. Retrovirology 7, 19
15. Guo, X., Carroll, J. W., Macdonald, M. R., Goff, S. P., and Gao, G. (2004) The zinc-finger antiviral protein directly binds to specific viral mRNAs through the CCCH zinc-finger motifs. J. Virol. 78, 12781-12787 (Pubitemid 39507786)
16. Blom, N., Gammeltoft, S., and Brunak, S. (1999) Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J. Mol. Biol. 294, 1351-1362 (Pubitemid 30008805)
17. Coghlan, M. P., Culbert, A. A., Cross, D. A., Corcoran, S. L., Yates, J. W., Pearce, N. J., Rausch, O. L., Murphy, G. J., Carter, P. S., Roxbee Cox, L., Mills, D., Brown, M. J., Haigh, D., Ward, R. W., Smith, D. G., Murray, K. J., Reith, A. D., and Holder, J. C. (2000) Selective small-molecule inhibitors of glycogen synthase kinase 3 modulate glycogen metabolism and gene transcription. Chem. Biol. 7, 793-803
18. Ishiguro, K., Omori, A., Takamatsu, M., Sato, K., Arioka, M., Uchida, T., and Imahori, K. (1992) Phosphorylation sites on tau by tau protein kinase I, a bovine-derived kinase generating an epitope of paired helical filaments. Neurosci. Lett. 148, 202-206 (Pubitemid 23007739)
19. Imahori, K., and Uchida, T. (1997) Physiology and pathology of tau protein kinases in relation to Alzheimer disease. J. Biochem. 121, 179-188 (Pubitemid 27096190)
20. Liu, C., Li, Y., Semenov, M., Han, C., Baeg, G. H., Tan, Y., Zhang, Z., Lin, X., and He, X. (2002) Control of β-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 108, 837-847 (Pubitemid 34327534)
21. Cohen, P., and Frame, S. (2001) The renaissance of GSK3. Nat. Rev. Mol. Cell Biol. 2, 769-776 (Pubitemid 33679839)
22. Eldar-Finkelman, H. (2002) Glycogen synthase kinase 3: an emerging therapeutic target. Trends Mol. Med. 8, 126-132
23. Lochhead, P. A., Coghlan, M., Rice, S. Q., and Sutherland, C. (2001) Inhibition of GSK3 selectively reduces glucose-6-phosphatase and phosphatase and phosphoenolypyruvate carboxykinase gene expression. Diabetes 50, 937-946 (Pubitemid 32374522)
24. Grimes, C. A., and Jope, R. S. (2001) The multifaceted roles of glycogen synthase kinase 3β in cellular signaling. Prog. Neurobiol. 65, 391-426 (Pubitemid 32781670)
25. Hernández, F., and Avila, J. (2008) The role of glycogen synthase kinase 3 in the early stages of Alzheimer disease. FEBS Lett. 582, 3848-3854
26. Jope, R. S. (1999) Anti-bipolar therapy: mechanism of action of lithium. Mol. Psychiatry 4, 117-128
27. Manoukian, A. S., and Woodgett, J. R. (2002) Role of glycogen synthase kinase 3 in cancer: regulation by Wnts and other signaling pathways. Adv. Cancer Res. 84, 203-229 (Pubitemid 34188198)
28. Beurel, E., Michalek, S. M., and Jope, R. S. (2009) Innate and adaptive immune responses regulated by glycogen synthase kinase 3 (GSK3). Trends Immunol. 31, 24-31
29. Martin, M., Rehani, K., Jope, R. S., and Michalek, S. M. (2005) Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat. Immunol. 6, 777-784 (Pubitemid 43090463)
30. Lei, C. Q., Zhong, B., Zhang, Y., Zhang, J., Wang, S., and Shu, H. B. (2010) Glycogen synthase kinase 3β regulates IRF3 transcription factor-mediated antiviral response via activation of the kinase TBK1. Immunity 33, 878-889
31. Luna-Medina, R., Cortes-Canteli, M., Sanchez-Galiano, S., Morales-Garcia, J. A., Martinez, A., Santos, A., and Perez-Castillo, A. (2007) NP031112, a thiadiazolidinone compound, prevents inflammation and neurodegeneration under excitotoxic conditions: potential therapeutic role in brain disorders. J. Neurosci. 27, 5766-5776 (Pubitemid 350021090)
32. Medina, M., and Castro, A. (2008) Glycogen synthase kinase 3 (GSK3) inhibitors reach the clinic. Curr. Opin. Drug Discov. Devel. 11, 533-543 (Pubitemid 351950847)
33. Hernández, F., Nido, J. D., Avila, J., and Villanueva, N. (2009) GSK3 inhibitors and disease. Mini-Rev. Med. Chem. 9, 1024-1029
34. Wagman, A. S., Johnson, K. W., and Bussiere, D. E. (2004) Discovery and development of GSK3 inhibitors for the treatment of type 2 diabetes. Curr. Pharm. Des. 10, 1105-1137